SynthesisPediatric surgery international2026
The effect of autologous platelet-rich treatment in hypospadias repair: a systematic review and meta-analysis.
Synthesis in Pediatric surgery international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundHypospadias is one of the most common male congenital anomalies and often requires a surgical approach. Several repair techniques have been developed to improve the outcomes, including the autologous platelet-rich treatment (APT). There remains a controversy that whether the application of APT really benefits hypospadias repair. MATERIALS AND
methodsThe current study was performed based on the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) 2020 guidelines and was registered. The systematic literature search was undertaken using PubMed, Embase, Web of Science and Cochrane Central Register of Controlled Trials databases to identify eligible studies published before May 2025. The primary outcomes included operative time, length of hospital stay, urethral fistula, meatal stenosis, urethral stricture, wound infection, glans dehiscence, bleeding and total complication rates.
resultsTotally 562 pediatric patients from 7 independent controlled trials including 5 randomized controlled trials (RCTs) were obtained for the final analysis. In the comparison between the APT group and non-APT group, no significant difference was found as regards operation time, hospital stay, glans dehiscence and urethral stricture. However, the APT group may exhibit potential benefits in urethral fistula (OR:0.51, 95%CI: 0.29–0.91, p = 0.02), meatal stenosis (OR:0.35, 95%CI: 0.14–0.90, p = 0.03), wound infection (OR:0.19, 95%CI: 0.07–0.46, p < 0.001) and total complications (OR:0.30, 95%CI: 0.16–0.55, p < 0.001).
conclusionsAPT was an efficient and safe procedure in the management of hypospadias repair. Compared with non-APT group, the application of APT was associated with decreased postoperative complications including urethral fistula, meatal stenosis and wound infection. More RCTs with larger sample size are still needed.
Indexed as
Identifiers
42001334What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.